Glipizide and Metformin Articles
Final FDA appro for Caraco's generic Metaglip
21 January 2008
Final FDA OK for Mylan's generic of B-MS' Metaglip
23 April 2007
Strong 4th-quarter operating results at Merck KGaA on flat sales
24 February 2003
Showing 1-3 of 3 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
